[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"primary-headache-disorders\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:primary-headache-disorders":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100628376",false,"NCT07460830","Serum Uric Acid in Adolescents With Primary Headache: A Case-Control Study","Association Between Serum Uric Acid Levels and Primary Headaches in Adolescents: A Case-Control Study","Inclusion Criteria:\n\n* Inclusion Criteria (Cases):\n\nAdolescents aged 12-18 years presenting to pediatric neurology outpatient clinics\n\nDiagnosis of primary headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) (e.g., 1.1, 1.2, etc.)\n\nDiagnosis confirmed by a pediatric neurologist following a comprehensive clinical evaluation\n\nSufficient cognitive ability to understand and complete study instruments\n\n* Inclusion Criteria (Controls):\n\nAdolescents aged 12-18 years presenting to general pediatric outpatient clinics\n\nNo history of recurrent headaches\n\nNo chronic medical or psychiatric disorders\n\nMatched with the case group for age and sex\n\nExclusion Criteria:\n\n* History of neurological disorders other than primary headache\n* Previously diagnosed psychiatric conditions\n* Autoimmune diseases, chronic infections, severe cardiac failure, metabolic or inflammatory disorders, obesity, or significant hepatic or renal impairment\n* Regular use of psychotropic medications or a history of polycythemia\n* Use of drugs known to affect uric acid metabolism within 2-4 weeks prior to enrollment\n* Cognitive or developmental disabilities limiting the ability to understand or complete study instruments","ALL","12 Years","18 Years",{"count":19,"type":20},80,"ESTIMATED","1 Day","OBSERVATIONAL","This observational, case-control study will evaluate differences in serum uric acid and related hematologic and biochemical parameters between adolescents (12-18 years) with primary headache and age-\u002Fsex-matched controls without recurrent headaches or chronic medical\u002Fpsychiatric disorders. Cases will meet International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria verified by a pediatric neurologist after comprehensive clinical assessment. The study will also collect sociodemographic data and anthropometrics to calculate BMI. Primary outcome is the between-group difference in serum uric acid levels at enrollment. Secondary outcomes include group differences in ferritin, creatinine, BUN, complete blood count indices (Hb, WBC, neutrophils, lymphocytes, platelets, MPV), and BMI.",[25],"Primary Headache Disorders","NOT_YET_RECRUITING","2026-03-04",{"date":29,"type":30},"2026-03-10","ACTUAL",{"date":32,"type":20},"2026-03-15",{"date":34,"type":20},"2026-05-15",{"name":36,"class":37},"Konya Necmettin Erbakan Üniversitesi","OTHER",""]